NASDAQ:BIOT Biotech Acquisition (BIOT) Stock Price, News & Analysis → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free BIOT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$10.14▼$10.1950-Day Range$10.08▼$10.3252-Week Range$8.30▼$10.41Volume44,400 shsAverage Volume244,605 shsMarket Capitalization$291.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Biotech Acquisition alerts: Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution About Biotech Acquisition Stock (NASDAQ:BIOT)Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.Read More Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution BIOT Stock News HeadlinesMay 23 at 10:33 AM | finance.yahoo.comResource Label Group expands RLG Healthcare business with acquisition of Beyer GraphicsMay 22 at 6:26 PM | finance.yahoo.comSixPeaks, a new obesity biotech, starts up with an option to sell to AstraZenecaMay 22 at 1:23 PM | markets.businessinsider.comHBM Healthcare Investments' portfolio company Swixx BioPharma boosts sales and profits through strategic acquisition in Latin AmericaMay 22 at 8:22 AM | finance.yahoo.comGenmab acquires biotechnology company ProfoundBio in $1.8bn dealMay 22 at 2:12 AM | msn.comKKR, Blackstone, Carlyle, Mankind Pharma eye acquisition of Advent-owned Bharat Serums & VaccinesMay 20 at 8:07 AM | msn.comAjooni Biotech Ltd's Rs 43.81 crores Rights opens on May 21, 2024May 17, 2024 | markets.businessinsider.comBuy Rating Affirmed for Ultragenyx Pharmaceutical Based on Clinical Updates and Market Valuation DisconnectMay 16, 2024 | msn.comJohnson & Johnson to buy dermatology-focused biotech ProteologixMay 16, 2024 | msn.comMankind Pharma: Strong Q4, Acquisition Reports Not Enough To Power StockMay 15, 2024 | bizjournals.comRaleigh clinical research firm expands in four states with acquisitionMay 15, 2024 | msn.comPharmaceutical giant Bayer AG trims workforce by 1500 amid slight sales declineMay 15, 2024 | msn.comBiopharmaceutical mergers and acquisitions surge to new highsMay 10, 2024 | bizjournals.comA second co-founder has left Forge Biologics following its more than $600M acquisitionMay 8, 2024 | bizjournals.comD.C. biotech mulling sweetened acquisition offerMay 8, 2024 | msn.comMyonex Expands Pharmaceutical Services with Acquisition of CreapharmMay 8, 2024 | finance.yahoo.comArbor Biotechnologies Announces Acquisition of SerendipityMay 3, 2024 | finance.yahoo.comEphicacy Consulting Group Completes Acquisition of Advance Research AssociatesMay 2, 2024 | bizjournals.comHow Moderna's cost-cutting moves hit a Bay Area biotechMay 1, 2024 | bizjournals.comAccounting giant wants to grow Albany footprint after Nuvalence acquisitionApril 29, 2024 | msn.comDeciphera Agrees to $2.4 Billion Buyout Offer From Japan's ONO PharmaceuticalApril 29, 2024 | markets.businessinsider.comDeciphera Up In Pre-market On News Of Acquisition By ONO Pharmaceutical For About $2.4 BlnApril 26, 2024 | msn.comEli Lilly’s acquisition of Nexus facility marks a new era for Pleasant Prairie’s pharmaceutical landscapeApril 26, 2024 | finanznachrichten.deSagaliam Acquisition Corp. Announces Novation Agreement with Enzolytics, Inc.April 26, 2024 | markets.businessinsider.comBuy Rating on Danaher: Strong Biotech Performance and Growth Potential Despite Market ChallengesApril 26, 2024 | msn.comPhiladelphia-based Century Therapeutics Acquires Boston Biotechnology Firm Clade TherapeuticsSee More Headlines Receive BIOT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/23/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:BIOT CUSIPN/A CIK1825413 Webbioacq.com Phone212-227-1905FaxN/AEmployees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,860,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-42.22% Return on Assets3.48% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.95) per share Price / Book-10.68Miscellaneous Outstanding Shares28,750,000Free Float23,288,000Market Cap$291.81 million OptionableNot Optionable Beta-0.12 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Michael Shleifer Ph.D. (Age 48)Chairman & CEO Mr. Thomas Fratacci (Age 44)CFO & Treasurer Mr. Ivan Jarry (Age 44)Chief Operating Officer Mr. Albert F. Hummel M.B.A. (Age 76)Chief Investment Officer & Director Key CompetitorsNature's Sunshine ProductsNASDAQ:NATRMacroGenicsNASDAQ:MGNXXeris BiopharmaNASDAQ:XERSVerastemNASDAQ:VSTMXOMANASDAQ:XOMAView All Competitors This page (NASDAQ:BIOT) was last updated on 5/23/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe Presidential candidate you should REALLY be worried aboutStansberry ResearchWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsNew Options need New Trading StrategiesNetpicksExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotech Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.